Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FH3A6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,020
Award facts
- Contract value 100% obligated
- $17,020.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $17,020.12 by the Defense Logistics Agency (DLA) on September 23, 2025, for the supply of Cosentyx (secukinumab) 300 mg pen injections in 2 mL formulations. The contract is not set aside and employs firm fixed pricing, with an ultimate completion date of September 24, 2025. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is executed as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026.
The DLA Troop Support Medical IDC serves as a global pharmaceutical prime vendor contract enabling AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The contract supports critical federal healthcare customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's federal contract portfolio demonstrates consistent capability in competitively awarded pharmaceutical procurement, with delivery orders ranging from minimal amounts to substantial orders exceeding $45,000, reflecting the company's versatility in fulfilling diverse medical supply requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FH3A6?
SPE2DB25FH3A6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FH3A6 worth?
The government has obligated $17,020 on SPE2DB25FH3A6.
Is contract SPE2DB25FH3A6 an order under another contract?
Yes. SPE2DB25FH3A6 is a delivery order under SPE2DB22D1103, an indefinite delivery contract.
Was contract SPE2DB25FH3A6 competed?
The extent of competition for SPE2DB25FH3A6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award